The association between drospirenone and hyperkalemia: a comparative-safety study (Q34114759)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22208934%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

The association between drospirenone and hyperkalemia: a comparative-safety study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22208934%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22208934%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22208934%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Steven T Bird

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22208934%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Salvatore R Pepe

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22208934%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mahyar Etminan

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22208934%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Xinyue Liu

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22208934%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

30 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22208934%20AND%20SRC:MED&resulttype=core&format=json

BMC Clinical Pharmacology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22208934%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22208934%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22208934%20AND%20SRC:MED&resulttype=core&format=json

Pharmacotherapy of polycystic ovary syndrome--an update

19 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

Management strategies for premenstrual syndrome/premenstrual dysphoric disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

The concomitant prescribing of ethinyl estradiol/drospirenone and potentially interacting drugs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

Safety of a new oral contraceptive containing drospirenone

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity

5 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

5 July 2018

https://api.crossref.org/works/10.1186%2F1472-6904-11-23

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-11-23

Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 microg of ethinyl estradiol on the human endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-11-23

A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-11-23

The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-11-23

A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-11-23

Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265420

Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception

28 October 2018

1 reference

12 December 2020

Effects of a New Hormone Therapy, Drospirenone and 17-β-Estradiol, in Postmenopausal Women With Hypertension

1 reference

12 December 2020

Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study

1 reference

12 December 2020

An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6904-11-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22208934%20AND%20SRC:MED&resulttype=core&format=json

release_qcuu25bxqvfkzc3whxwpe7k2xa

19 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qcuu25bxqvfkzc3whxwpe7k2xa

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22208934%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

PubMed publication ID

22208934

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22208934%20AND%20SRC:MED&resulttype=core&format=json